Am J Respir Crit Care Med 2009, 180:138–145 PubMedCrossRef 21 He

Am J Respir Crit Care Med 2009, 180:138–145.HMPL-504 mouse PubMedCrossRef 21. Heijerman H, Westerman E, Conway S, Touw D, Döring G: Consensus Working Group: Inhaled medication and inhalation devices for lung diseases in patients with cystic

fibrosis: a European consensus. J Cyst Fibros 2009, 8:295–315.PubMedCrossRef 22. Fothergill JL, Walshaw check details MJ, Winstanley C: Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 2012, 40:227–238.PubMedCrossRef 23. Scott FW, Pitt TL: Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 2004, 53:609–615.PubMedCrossRef 24. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, Paterson N, Jackson M, Lougheed MD, Dowson C, Kumar V, Ferris W, Chan F, Doucette S, Fergusson D: Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA – J Am Med Assoc 2010, 304:2145–2153.CrossRef 25. Panagea S, Winstanley C, Parsons YN, Walshaw MJ, Ledson

MJ, Hart CA: PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa . Mol Diagn 2003, 7:195–200.PubMed 26. Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ: Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004, 59:334–336.PubMedCrossRef 27. Ashish A, Shaw M, McShane J, Ledson MJ, Walshaw MJ: Health-related quality of life in Cystic Fibrosis patients infected with transmissible P005091 in vivo Pseudomonas aeruginosa strains: cohort study. JRSM Short Reports 2012, 3:12.PubMedCrossRef 28. Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, Whitchurch CB, Manos RG7420 J: Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol 2010, 59:1089–1100.PubMedCrossRef 29. Garbe

J, Wesche A, Bunk B, Kazmierczak M, Selezska K, Rohde C, Sikorski J, Rohde M, Jahn D, Schobert M: Characterization of JG024, a Pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions. BMC Microbiol 2010, 10:301.PubMedCrossRef 30. Sriramulu DD, Lunsdorf H, Lam JS, Romling U: Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 2005, 54:667–676.PubMedCrossRef 31. Blazquez J, Gomez-Gomez JM, Oliver A, Juan C, Kapur V, Martin S: PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa . Mol Microbiol 2006, 62:84–99.PubMedCrossRef 32. Perez-Capilla T, Baquero MR, Gomez-Gomez JM, Ionel A, Martin S, Blazquez J: SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli .

Comments are closed.